Matches in Wikidata for { <http://www.wikidata.org/entity/Q37080458> ?p ?o ?g. }
- Q37080458 description "2013 թվականի հունիսի 10-ին հրատարակված գիտական հոդված" @default.
- Q37080458 description "article científic" @default.
- Q37080458 description "article scientifique" @default.
- Q37080458 description "articolo scientifico" @default.
- Q37080458 description "artigo científico" @default.
- Q37080458 description "artículu científicu espublizáu en 2013" @default.
- Q37080458 description "bilimsel makale" @default.
- Q37080458 description "scientific article published on 10 June 2013" @default.
- Q37080458 description "vedecký článok" @default.
- Q37080458 description "vetenskaplig artikel" @default.
- Q37080458 description "videnskabelig artikel" @default.
- Q37080458 description "vědecký článek" @default.
- Q37080458 description "wetenschappelijk artikel" @default.
- Q37080458 description "wissenschaftlicher Artikel" @default.
- Q37080458 description "наукова стаття, опублікована в червні 2013" @default.
- Q37080458 description "научни чланак" @default.
- Q37080458 description "مقالة علمية نشرت في 10 يونيو 2013" @default.
- Q37080458 name "Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia" @default.
- Q37080458 name "Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia" @default.
- Q37080458 name "Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia" @default.
- Q37080458 type Item @default.
- Q37080458 label "Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia" @default.
- Q37080458 label "Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia" @default.
- Q37080458 label "Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia" @default.
- Q37080458 prefLabel "Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia" @default.
- Q37080458 prefLabel "Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia" @default.
- Q37080458 prefLabel "Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia" @default.
- Q37080458 P1433 Q37080458-777C1620-21DF-4A13-B95F-70610F6E4C0D @default.
- Q37080458 P1476 Q37080458-9F41F362-0AC7-4702-9C93-F6D63157D86F @default.
- Q37080458 P2093 Q37080458-80A69AD5-33F2-4372-B2D3-7D85955CB365 @default.
- Q37080458 P2093 Q37080458-C802FAA3-0733-42BC-A555-3A49541868C9 @default.
- Q37080458 P2093 Q37080458-E114BA2F-0F10-456B-8297-52514699EB41 @default.
- Q37080458 P2093 Q37080458-EAEA837C-7B64-48EF-86D8-88C0C34B65F9 @default.
- Q37080458 P2093 Q37080458-F6DD8977-71AF-4EA9-A8F3-8934BB609B61 @default.
- Q37080458 P2860 Q37080458-1442DA9A-C767-464F-BA2D-C8C5C2ED77AC @default.
- Q37080458 P2860 Q37080458-22240F86-0C75-46AF-96DE-2F532C4F64B5 @default.
- Q37080458 P2860 Q37080458-283F61B2-A38F-45A5-BDBA-EBB4216D5467 @default.
- Q37080458 P2860 Q37080458-316508EA-694D-4253-8DE8-E6463740BE74 @default.
- Q37080458 P2860 Q37080458-54131407-8E6D-40F3-A3BA-AFA3CCDF90BE @default.
- Q37080458 P2860 Q37080458-57F4429E-2568-4C35-BDC3-FB7292C83CCD @default.
- Q37080458 P2860 Q37080458-8B1E5AEE-763F-4357-9336-7D4A9AD977EC @default.
- Q37080458 P2860 Q37080458-8E0E7B72-367E-489C-8C37-952B1172A7F4 @default.
- Q37080458 P2860 Q37080458-9B31D317-872A-4F20-B8E4-7F713E0607CC @default.
- Q37080458 P2860 Q37080458-A2E4986F-A351-4C99-90F5-6B9A7EEA0F1F @default.
- Q37080458 P2860 Q37080458-A777EDDD-418E-4DA0-930E-6388782A0E62 @default.
- Q37080458 P2860 Q37080458-AFD43E6F-2363-494F-AD4D-BA4677071D3F @default.
- Q37080458 P2860 Q37080458-D5A47DE5-CBBF-427C-AFCF-E8EFE7689564 @default.
- Q37080458 P2860 Q37080458-DB5455C0-559F-4A24-AFEE-EA3CA13885FF @default.
- Q37080458 P2860 Q37080458-DFDB2575-D8C0-4CC4-9145-35C236E0B937 @default.
- Q37080458 P2860 Q37080458-FC4D47FC-44E1-4DC4-A8D0-AD4F006352FD @default.
- Q37080458 P304 Q37080458-B9CD8960-75F5-4937-B715-779B0BACF6C8 @default.
- Q37080458 P31 Q37080458-A12E21B0-7420-4AF0-8CBF-209C06AE8774 @default.
- Q37080458 P356 Q37080458-B72DA644-CAF6-453A-AF3D-FEDF4D9EA89D @default.
- Q37080458 P407 Q37080458-37DF963D-3BC9-4112-A88E-471C56996FFF @default.
- Q37080458 P433 Q37080458-CCEE278D-08BD-42BE-BE4E-442C6231FB45 @default.
- Q37080458 P478 Q37080458-63586014-7EA1-42C3-A22A-15A285068B3B @default.
- Q37080458 P50 Q37080458-070B6639-3D0F-45F3-886C-E3B7FAE92EA9 @default.
- Q37080458 P50 Q37080458-0F12BB13-8833-4E4C-8D9C-35010076E1F8 @default.
- Q37080458 P50 Q37080458-321DA9D6-DB92-45A7-9771-23667ED96D86 @default.
- Q37080458 P50 Q37080458-B65F6589-8E78-4070-BD5C-40B20A486BD3 @default.
- Q37080458 P50 Q37080458-E0F5E3BE-93E2-4AE3-A29F-5B63902D735D @default.
- Q37080458 P577 Q37080458-2F5C0BB1-58DA-43B1-8CA3-FC75D72DA7CD @default.
- Q37080458 P698 Q37080458-0F048C12-9BBA-4217-8C69-930217315CC9 @default.
- Q37080458 P921 Q37080458-34696CD6-6A4F-4655-BF28-B040CAFCF7F2 @default.
- Q37080458 P921 Q37080458-3D146800-4837-4F4F-90F0-7C9C64FC974A @default.
- Q37080458 P921 Q37080458-817867D0-ABF8-4021-8647-5031F16E6207 @default.
- Q37080458 P932 Q37080458-E8BA7EA3-812B-4232-BBC5-AB5B22A4ED59 @default.
- Q37080458 P356 J.CLML.2013.03.015 @default.
- Q37080458 P698 23763920 @default.
- Q37080458 P1433 Q5133774 @default.
- Q37080458 P1476 "Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia" @default.
- Q37080458 P2093 "Debora A Thomas" @default.
- Q37080458 P2093 "Laurie A Ford" @default.
- Q37080458 P2093 "Robert Shepard" @default.
- Q37080458 P2093 "Samir Parekh" @default.
- Q37080458 P2093 "Thompson L Heffner" @default.
- Q37080458 P2860 Q33335506 @default.
- Q37080458 P2860 Q33343161 @default.
- Q37080458 P2860 Q33386616 @default.
- Q37080458 P2860 Q34131844 @default.
- Q37080458 P2860 Q35828662 @default.
- Q37080458 P2860 Q40667178 @default.
- Q37080458 P2860 Q43824593 @default.
- Q37080458 P2860 Q44132690 @default.
- Q37080458 P2860 Q46360551 @default.
- Q37080458 P2860 Q53388335 @default.
- Q37080458 P2860 Q54319513 @default.
- Q37080458 P2860 Q71228788 @default.
- Q37080458 P2860 Q73166090 @default.
- Q37080458 P2860 Q73399572 @default.
- Q37080458 P2860 Q82871158 @default.
- Q37080458 P2860 Q95439159 @default.
- Q37080458 P304 "430-434" @default.
- Q37080458 P31 Q13442814 @default.
- Q37080458 P356 "10.1016/J.CLML.2013.03.015" @default.
- Q37080458 P407 Q1860 @default.
- Q37080458 P433 "4" @default.
- Q37080458 P478 "13" @default.
- Q37080458 P50 Q60394812 @default.
- Q37080458 P50 Q66370727 @default.